Early Rule Out of Myocardial Infarction With a Novel High-Sensitivity Cardiac Troponin T Assay.
Alexander J F Thurston, Yong Yong Tew, Pedro Lopez-Ayala...
https://pubmed.ncbi.nlm.nih.gov/42018311/Actively Recruiting
Led by University of Edinburgh · Updated on 2026-07-07
19500
Participants Needed
3
Research Sites
52 weeks
Total Duration
Researchers are evaluating a new sixth-generation high-sensitivity cardiac troponin T test to diagnose heart attacks more quickly among patients with suspected acute coronary syndrome. This diagnostic study aims to determine if using this advanced test reduces the time patients spend in Emergency Departments while maintaining patient safety. The study compares data from one year before and one year after introducing the new test across a health board, using routinely collected hospital data and blood samples. The study involves two groups patients evaluated with the current fifth-generation troponin test before the new tests implementation, and those evaluated with the sixth-generation test afterward. The sixth-generation Elecsys Troponin T hs Gen 6 assay is designed to be more precise and less affected by interference than the previous version. Researchers will measure troponin levels from surplus blood samples collected during two six-month periods before and after the new tests introduction to directly compare the tests. Participants will not need to take any extra actions as the study uses data and samples collected during usual care. Researchers will examine Emergency Department length of stay as the primary outcome, along with hospital admission, cardiovascular events, and mortality up to one year. The study will also monitor serial troponin measurements and other clinical outcomes to assess the new tests impact on patient care and safety over time.
CONDITIONS
Sixth Generation High-sensitivity Cardiac Troponin T for the Early Rule Out of Myocardial Infarction: a Controlled Before and After Study
A
Andrew R Chapman, MD PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Edinburgh
Lead Sponsor
Roche Diagnostic Ltd.
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 months
Participants receive care guided by the current fifth-generation high-sensitivity cardiac troponin T test. Data and blood samples are collected during this time to establish baseline measures.
Duration - 12 months
Participants receive care guided by the new sixth-generation high-sensitivity cardiac troponin T test. Data and blood samples continue to be collected to evaluate the new test's impact on diagnosis and patient care.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Alexander J F Thurston, Yong Yong Tew, Pedro Lopez-Ayala...
https://pubmed.ncbi.nlm.nih.gov/42018311/Jasper Boeddinghaus, Ziwen Li, Anda Bularga...
https://pubmed.ncbi.nlm.nih.gov/41405901/University of Edinburgh
Lead Sponsor
Roche Diagnostic Ltd.
Collaborating Sponsor